Journal list Promote Sponsor
verified SJR 0,803 · Q1 • database Scopus / SJR & Web of Science indexed
Experimental and Molecular Pathology
United States · Academic Press Inc.
workspace_premium Q1 — Molecular Biology lock Subscription

Experimental and Molecular Pathology

Experimental and Molecular Pathology is a journal indexed in SJR in Molecular Biology and Pathology and Forensic Medicine with an H index of 81. It has an SJR impact factor of 0,803 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 0,803.

Experimental and Molecular Pathology focuses its scope in these topics and keywords: cancer, cells, invasion, responses, proteins, ratsclonal, acyltransferase, redoxsensitive, overexpression, poolknockdown, ...

ISSN: 0014-4800
Publisher: Academic Press Inc.
Category: Molecular Biology
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Portal NPD menu_book Guidelines NPD
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
0,803 Q1
H-index 81
Acceptance rate pie_chart
27% Selective
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
NPD Subscription
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,803

H-index

81

Docs (year)

45

Docs 3y

170

Total refs

3065

Cites 3y

538

Citable 3y

169

Cites/Doc 2y

3.89

Ref/Doc

68.11

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

FAQs